Cargando…
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
BACKGROUND: Individuals with primary and secondary immunodeficiency (PID/SID) were shown to be at risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic. SARS-CoV-2 vaccines demonstrate reduced immunogenicity in these patients. OBJECTIVES: To understand whether the risk of severe C...
Autores principales: | Shields, Adrian M., Tadros, Susan, Al-Hakim, Adam, Nell, Jeremy M., Lin, Me Me Nay, Chan, Michele, Goddard, Sarah, Dempster, John, Dziadzio, Magdalena, Patel, Smita Y., Elkalifa, Shuayb, Huissoon, Aarnoud, Duncan, Christopher J. A., Herwadkar, Archana, Khan, Sujoy, Bethune, Claire, Elcombe, Suzanne, Thaventhiran, James, Klenerman, Paul, Lowe, David M., Savic, Sinisa, Burns, Siobhan O., Richter, Alex G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539662/ https://www.ncbi.nlm.nih.gov/pubmed/36211396 http://dx.doi.org/10.3389/fimmu.2022.984376 |
Ejemplares similares
-
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study
por: Shields, Adrian M., et al.
Publicado: (2022) -
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study
por: Shields, Adrian M., et al.
Publicado: (2022) -
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
por: Shields, Adrian M, et al.
Publicado: (2022) -
T-cell abnormalities in common variable immunodeficiency: the hidden defect
por: Wong, Gabriel K, et al.
Publicado: (2016) -
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
por: Chan, Michele, et al.
Publicado: (2023)